abstract id no: iria - 1085 role of diffusion weighted imaging in uterine and cervical lesions

25
ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

Upload: kerry-hodges

Post on 17-Dec-2015

217 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

ABSTRACT ID NO: IRIA - 1085

ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

Page 3: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

REVIEW OF LITERATURE

Role of diffusion weighted imaging in the diagnosis of gynecological diseases : Tomohiro Namimoto,Kazuo Awai,Takeshi Nakaura,Yumi Yanaga :

European Society of Radiology 2008

Page 4: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

Important cancer biomarker

Aids in superior lesion characterization, tumor staging, treatment planning, and disease follow-up of gynaecological tumors

Help predict and assess treatment response earlier than other techniques

Can detect residual / recurrent tumor

REVIEW OF LITERATURE

Diffusion-weighted Imaging of Gynecologic Tumors: Diagnostic Pearls and Potential Pitfalls : Sunita Dhanda, et al

Radiographics 2014 :34:1393–1416

Page 5: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

To assess role of Diffusion weighted imaging (DWI) in differentiating benign from malignant lesions of uterus and cervix

AIM

Page 6: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

24 patients with uterine and cervical lesions15 control patients with normal uterus and cervixDWI  with b value 800 as a part of routine MR imaging on 1.5T MRIApparent diffusion coefficient (ADC) calculated and correlated with histopathologyInclusion criteria: Patients with lesions of uterus and cervix who have undergone MRI and who have HPE follow up Exclusion criteria: Patients who have contraindications to MR imaging and who have no HPE follow up

MATERIALS AND METHODS

Page 7: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

Name

Age

Hospital No

Date Of MRI Study

Clinical History

Previous USG,CT,MRI findings

Findings at MRI with special emphasis on DWI

Clinical Follow Up

HPE Diagnosis

PROFORMA

Page 8: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

PATHOLOGIES

(n=2)

(n=12)

(n=5)

(n=5)

Page 9: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

CARCINOMA ENDOMETRIUM

T2 WI

ADC :0.648x10-3mm2/s

DWIADC

F/65, Post menopausal bleeding

Page 10: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

CARCINOMA ENDOMETRIUM

ADC 0.712 x10-3mm2/s

T2 WI

DWIADC

F/52, Menorrhagia

Page 11: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

ADC :Normal Endometrium

S.NO. CONTROL ADC VALUES (X 10-3mm2/s)

1. 1.42

2. 1.29

3. 1.33

4. 1.43

5. 1.59

6. 1.45

7. 1.34

8. 1.46

9. 1.42

10. 1.42

11. 1.47

12. 1.59

13. 1.42

14. 1.49

15. 1.41

S.No ADC VALUES (X 10-3mm2/s)

1. 1.29

2. 0.712

3. 0.619

4. 0.94

5. 0.981

Range: 1.29 to 1.59 x 10-3mm2/sMean ADC : 1.44 x 10-3 mm2/s

Range :0.619 to 1.29 x 10-3mm2/s Mean ADC : 0.88 x 10-3mm2/s

ADC :Ca Endometrium

Page 12: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

NPAR TESTSMANN-WHITNEY TEST

RANKS TEST STATISTICS

a. Grouping Variable: ANN

b. Not corrected for ties

Page 13: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

CARCINOMA CERVIX

T2 WI

ADC:0.923x10-3mm2/s

DWI ADC

F/57Post menopausal bleeding

Page 14: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

CARCINOMA CERVIX

ADC 0.977 x 103mm2/s

T2 WI

DWIADC

F/57 ,White discharge

Page 15: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

ADC values of normal cervix

S.No CONTROL ADC VALUES X 10-3mm2/S

1 1.35

2 1.373 1.404 1.565 1.426 1.467 1.378 1.369 1.3410 1.3611 1.4312 1.3713 1.3614 1.3215 1.37

S.No ADC VALUES X 10-3mm2/S

1 0.618

2 1.104

3 0.886

4 1.012

5 0.977

Range :1.32 to 1.56 x10-3mm2/sMean ADC : 1.39 x10-3mm2/s

Range :0.618 to 1.012 x10-3mm2/sMean ADC :0.909 x10-3mm2/s

ADC values of Carcinoma cervix

Page 16: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

NPAR TESTSMANN-WHITNEY TEST

RANKS TEST STATISTICS

b. Not corrected for ties.

a. Grouping Variable: ANN

Page 17: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

LEIOMYOMA

T2 WI

ADC:1.616 x10-3mm2/s

DWIADC

F/43,Menorrhagia,dysmenorrhoea

Page 18: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

LEIOMYOMAS

T2 WI

ADC: 1.256 x10-3mm2/s

DWIADC

F/43Menorrhagia

Page 19: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

ADC values of normal myometrium

S.NO CONTROL ADC VALUES X 10-3mm2/s

1. 1.57

2. 1.39

3. 1.64

4. 1.68

5. 1.51

6. 1.54

7. 1.46

8. 1.54

9. 1.56

10. 1.52

11. 1.42

12. 1.54

13. 1.54

14. 1.53

15. 1.52

Range: 1.39 to 1.68 x10-3mm2/sMean ADC : 1.53 x10-3mm2/s

S.NO. ADC VALUES X 10-3mm2/s

1 2.27

2 1.77

3 1.59

4 1.53

5 1.54

6 1.206

7 1.828

8 2.059

9 1.616

10 1.256

11 2.1

12 1.41

ADC values of Leiomyoma

Range: 1.24 to 2.27 x10-3mm2/sMean ADC : 1.67x10-3mm2/s

Page 20: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

STATISTICAL ANALYSIS :T-TEST

Page 21: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

Independent Samples Test

Levene's Test for Equality of

Variances t-test for Equality of Means

F Sig. t dfSig. (2-tailed)

Mean Differe

nce

Std. Error

Difference

95% Confidence

Interval of the Difference

Lower UpperVALUES Equal

variances assumed

20.595 .000 -1.671 25 .107 -.14858

.08894 -.33176

.03459

Equal variances not assumed

-1.503 11.834 .159 -.14858

.09888 -.36436

.06720

STATISTICAL ANALYSIS (Cont…)

Page 22: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

ADENOMYOSIS

ADC values of adenomyosis : 1.458 x 10-3mm/s and 1.506 x 10-3mm/s

T2 WI

DWIADC

F/40Dysmenorrhea,

ADC: 1.506 x10-3mm2/s

Page 23: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

Significant reduction in ADC values of malignant lesions as compared to benign ones

Mean ADC of Ca Endometrium (0.88 x10-3mm2/s ) < Mean ADC of normal Endometrium (1.44 x10-3mm2/s )

Mean ADC of Ca Cervix (0.9 x10-3mm2/s) < Mean ADC of normal Cervix (1.39 x10-3mm2/s )

RESULTS

Page 24: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

CONCLUSION

DWI with quantification of ADC values plays a major role in distinguishing benign and malignant lesions

DWI should be part of routine MR protocol when imaging the uterus and cervix

Page 25: ABSTRACT ID NO: IRIA - 1085 ROLE OF DIFFUSION WEIGHTED IMAGING IN UTERINE AND CERVICAL LESIONS

THANK YOU..